Journal of Cardiac Failure
Volume 13, Issue 8 , Pages 663-667 , October 2007

BNP in Overweight and Obese Patients With Heart Failure: An Analysis Based on the BNP-LV Diastolic Wall Stress Relationship

  • Yoshitaka Iwanaga, MD

      Affiliations

    • Division of Cardiology, National Cardiovascular Center, Suita, Japan
    • Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • Yoshitaka Iwanaga, MD, is presently affiliated with the Division of Cardiology, Department of Internal Medicine, Kinki University School of Medicine, Osakasayama, Japan.
    • Corresponding Author InformationReprint requests: Yoshitaka Iwanaga, MD, Division of Cardiology, Department of Internal Medicine, Kinki University School of Medicine, 377–2 Ohno-Higashi, Osakasayama 589–8511, Japan.
  • ,
  • Yasuki Kihara, MD

      Affiliations

    • Department of Cardiovascular Medicine, Kobe City General Hospital, Kobe, Japan
  • ,
  • Shinichiro Niizuma, MD

      Affiliations

    • Division of Cardiology, National Cardiovascular Center, Suita, Japan
  • ,
  • Teruo Noguchi, MD

      Affiliations

    • Division of Cardiology, National Cardiovascular Center, Suita, Japan
  • ,
  • Hiroshi Nonogi, MD

      Affiliations

    • Division of Cardiology, National Cardiovascular Center, Suita, Japan
  • ,
  • Toru Kita, MD

      Affiliations

    • Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
  • ,
  • Yoichi Goto, MD

      Affiliations

    • Division of Cardiology, National Cardiovascular Center, Suita, Japan

Received 15 February 2007 ,Revised 3 May 2007 ,Accepted 4 May 2007.

References 

  1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA. 2004;291:2847–2850
  2. Martorell R, Khan LK, Hughes ML, Grummer-Strawn LM. Obesity in women from developing countries. Eur J Clin Nutr. 2000;54:247–252
  3. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–313
  4. Dunlap SH, Sueta CA, Tomasko L, Adams KF. Association of body mass, gender and race with heart failure primarily due to hypertension. J Am Coll Cardiol. 1999;34:1602–1608
  5. Krauss RM, Winston M, Fletcher BJ, Grundy SM. Obesity: impact on cardiovascular disease. Circulation. 1998;98:1472–1476
  6. de Divitiis O, Fazio S, Petitto M, Maddalena G, Contaldo F, Mancini M. Obesity and cardiac function. Circulation. 1981;64:477–482
  7. Alpert MA, Lambert CR, Terry BE, Cohen MV, Mukerji V, Massey CV, et al. Influence of left ventricular mass on left ventricular diastolic filling in normotensive morbid obesity. Am Heart J. 1995;130:1068–1073
  8. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38:789–795
  9. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004;43:1439–1444
  10. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med. 2005;165:55–61
  11. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161–167
  12. Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation. 2003;107:1278–1283
  13. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Niccholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000;355:1126–1130
  14. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol. 2006;47:742–748
  15. Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris BC, et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol. 2004;43:1590–1595
  16. McCord J, Mundy BJ, Hudson MP, Maisel AS, Hollander JE, Abraham WT, et al. Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med. 2004;164:2247–2252
  17. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594–600
  18. Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation. 2005;112:2163–2168
  19. Kennedy JW, Trenholme SE, Kasser IS. Left ventricular volume and mass from single plane cineangiocardiogram. A comparison of anteroposterior and right anterior oblique methods. Am Heart J. 1970;80:343–352
  20. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 1989;2:358–367
  21. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–458
  22. Douglas PS, Reichek N, Plappert T, Muhammad A, St John Sutton MG. Comparison of echocardiographic methods for assessment of left ventricular shortening and wall stress. J Am Coll Cardiol. 1987;9:945–951
  23. Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J. 2005;149:744–750
  24. van Kimmenade R, van Dielen F, Bakker J, Nijhuis J, Crijns H, Buurman W, et al. Is brain natriuretic peptide production decreased in obese subjects?. J Am Coll Cardiol. 2006;47:886–887
  25. Rivera M, Cortes R, Salvador A, Bertomeu V, de Burgos FG, Paya R, et al. Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of aetiology. Eur J Heart Fail. 2005;7:1168–1170
  26. Kalra PR, Tigas S. Regulation of lipolysis: natriuretic peptides and the development of cachexia. Int J Cardiol. 2002;85:125–132
  27. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webbpeploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050–1053
  28. Mukaddam-Daher S. Natriuretic peptides as therapeutic targets. Expert Opin Ther Targets. 2006;10:239–252
  29. Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol. 2003;91:891–894
  30. Daniels LB, Clopton P, Bhalla V, Krishnaswamy P, Nowak RM, McCord J, et al. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. Am Heart J. 2006;151:999–1005
  31. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from prospective cohort study. Circulation. 2004;109:1004–1009

 Supported by a research grant from the ONO Medical Research Foundation, a Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology and a Grant-in-Aid for Scientific Research from the Japan Society for the promotion of Science (18590774).

PII: S1071-9164(07)00164-9

doi: 10.1016/j.cardfail.2007.05.002

Journal of Cardiac Failure
Volume 13, Issue 8 , Pages 663-667 , October 2007